These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5420431)

  • 1. A simple procedure for accurate quantitation of factor VIII inhibitors.
    Tse D; Fekete L; Shanbrom E
    Thromb Diath Haemorrh; 1970 Feb; 23(1):19-25. PubMed ID: 5420431
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of patients having spontaneously occurring antibodies to antihaemophilic factor (factor VIII).
    Rizza CR; Edgcumbe JO; Pitney WR; Child JA
    Thromb Diath Haemorrh; 1972 Aug; 28(1):120-8. PubMed ID: 5074988
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of inhibitors to factor VIII.
    Kasper CK
    Prog Hematol; 1981; 12():143-63. PubMed ID: 6803298
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined factor VIII and IX inhibitors in a girl.
    Reussi C; Altman R; Rouvier J; Maino R
    Thromb Diath Haemorrh; 1966 Dec; 16(3):549-58. PubMed ID: 5996674
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous infusion of porcine factor VIII for the treatment of patients with factor VIII inhibitors.
    Bona RD; Riberio M; Klatsky AU; Panek S; Magnifico M; Rickles FR
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):32-5. PubMed ID: 8480196
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinicohaematological profile of two cases of inhibitors to factor VIII.
    Shanthala Devi AM; Srikrishna A; Sitalaksmi S; Damodar P
    Indian J Pathol Microbiol; 2001 Jul; 44(3):365-6. PubMed ID: 12024937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enhanced activity of diminished blood clotting factors in inborn blood coagulation defects].
    Mingers AM; Mietens C; Ströder J
    Thromb Diath Haemorrh; 1971 Jun; 25(2):316-31. PubMed ID: 5568051
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating anticoagulants.
    Zieve PD; Levin J
    Major Probl Intern Med; 1976; 10():65-70. PubMed ID: 785117
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemofil and other factor VIII concentrates.
    Med Lett Drugs Ther; 1969 Nov; 11(23):96. PubMed ID: 5375104
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical precision in therapy for coagulation disorders.
    Rosenthal MC
    N Y State J Med; 1968 Jun; 68(12):1695-8. PubMed ID: 5241095
    [No Abstract]   [Full Text] [Related]  

  • 11. Acquired Factor VIII inhibitor (a case report).
    Irby S; Rogers JS; Wolf DC
    W V Med J; 1983 Mar; 79(3):49-51. PubMed ID: 6405541
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO.
    W Collins P; Chalmers E; Hart D; Jennings I; Liesner R; Rangarajan S; Talks K; Williams M; R M Hay C;
    Br J Haematol; 2013 Sep; 162(6):758-73. PubMed ID: 23889317
    [No Abstract]   [Full Text] [Related]  

  • 13. Extracorporeal immunoadsorption for the treatment of coagulation inhibitors.
    Franchini M; Sassi M; Dell'Anna P; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Targher G; Lippi G
    Semin Thromb Hemost; 2009 Feb; 35(1):76-80. PubMed ID: 19308895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acquired coagulation factor VIII inhibitor in a non-hemophiliac patient].
    Polo Romero FJ; Fernández Fúnez A
    Rev Clin Esp; 1999 Feb; 199(2):114-5. PubMed ID: 10216409
    [No Abstract]   [Full Text] [Related]  

  • 15. An inhibitor of antihemophilic factor (factor VIII) in an 18-month-old nonhemophilic child.
    Stein J; Ratnoff OD
    Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):346-50. PubMed ID: 8328652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma and plasma fractions in the therapy of blood coagulation disorders].
    Lechler E
    Internist (Berl); 1974 Sep; 15(9):461-4. PubMed ID: 4609113
    [No Abstract]   [Full Text] [Related]  

  • 17. The management of factor VIII inhibitors in non-hemophilic patients.
    Green D
    Prog Clin Biol Res; 1984; 150():337-52. PubMed ID: 6431438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma exchange in non-haemophiliac patients with inhibitors to factor VIIIC.
    Erskine JG; Burnett AK; Walker ID; Davidson JF
    Br Med J (Clin Res Ed); 1981 Sep; 283(6294):760. PubMed ID: 6791738
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of a case of factor VIII inhibitor in an elderly female.
    Denham MJ; Sneath P; Walford DM
    Gerontol Clin (Basel); 1973; 15(1):10-4. PubMed ID: 4796450
    [No Abstract]   [Full Text] [Related]  

  • 20. Amidolytic end-point methods for factor VIIIC inhibitors.
    Mackie IJ; Seghatchian MJ
    Med Lab Sci; 1982 Oct; 39(4):345-50. PubMed ID: 6817016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.